View Financial HealthWaters 配当と自社株買い配当金 基準チェック /06Waters配当金を支払った記録がありません。主要情報n/a配当利回り-0.02%バイバック利回り総株主利回り-0.02%将来の配当利回り0%配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Aug 06Waters Corporation Provides Earnings Guidance for the Third Quarter Ending October 3, 2026 and Full Fiscal Year Ending December 31, 2026Waters Corporation provided earnings guidance for the third quarter ending October 3, 2026 and Full Fiscal Year ending December 31, 2026. For the quarter, Total Company reported revenue for the third quarter of 2026 is expected to be in the range of $1.745 billion to $1.762 billion. For the Full-Year, total Company reported revenue for full-year 2026 is expected to be in the range of $6.415 billion to $6.476 billion.Reported Earnings • Aug 04Second quarter 2026 earnings released: US$1.39 loss per share (vs US$2.47 profit in 2Q 2025)Second quarter 2026 results: US$1.39 loss per share (down from US$2.47 profit in 2Q 2025). Revenue: US$1.65b (up 113% from 2Q 2025). Net loss: US$136.0m (down 192% from profit in 2Q 2025). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Life Sciences industry in Europe.お知らせ • Jul 28Waters Corporation Launches Xevo TQ Absolute XR IVD Mass SpectrometerWaters Corporation announced the launch of the Xevo TQ Absolute XR IVD Mass Spectrometer, expanding its MassTrak IVD System portfolio of LC-MS/MS Systems with a solution that combines class-leading sensitivity and enhanced robustness for clinical applications. The new system builds on the industry-renowned step-change performance of the Xevo TQ Absolute IVD Mass Spectrometer, which established the benchmark for sensitivity among IVD-compliant tandem quadrupole mass spectrometers. Developed for routine laboratory testing requiring IVD-compliant systems, the Xevo TQ Absolute XR IVD System delivers exceptional trace-level analytical performance in complex biological matrices. With up to five times greater sensitivity than other instruments in its class, the system enables lower limits of detection and reliable quantification of challenging analytes from smaller sample volumes. This enhanced sensitivity is critical for applications requiring accurate measurement at very low concentrations, such as low-level estradiol testing for women's health and hormone-related cancer assessment, and hair toxicology for detecting drugs of abuse and documenting long-term exposure. Featuring the new StepWave XR Ion Guide, the Xevo TQ Absolute XR IVD System delivers improved robustness, enabling ion ratio consistency for up to six times longer compared with the Xevo TQ Absolute IVD System. This advancement gives laboratories greater confidence in consistent performance when analyzing complex clinical samples containing phospholipids, salts, and other matrix components. This new MassTrak LC-MS/MS IVD System includes the ACQUITY UPLC I-Class PLUS System with the Xevo TQ Absolute XR IVD Mass Spectrometer. The ACQUITY UPLC I-Class PLUS System is designed to deliver fast, accurate sample analysis that enhances mass spectrometer performance and simplifies the characterization of complex samples. Together, the integrated system delivers industry-leading sensitivity, enhanced robustness for complex sample matrices, and a user-friendly design that helps maximize laboratory uptime.お知らせ • Jul 02Waters Corporation to Report Q2, 2026 Results on Aug 04, 2026Waters Corporation announced that they will report Q2, 2026 results on Aug 04, 2026お知らせ • Jun 29+ 6 more updatesWaters Corporation(NYSE:WAT) dropped from Russell 3000 Growth BenchmarkWaters Corporation(NYSE:WAT) dropped from Russell 3000 Growth Benchmark決済の安定と成長配当データの取得安定した配当: WAZの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: WAZの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Waters 配当利回り対市場WAZ 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (WAZ)n/a市場下位25% (DE)1.5%市場トップ25% (DE)4.7%業界平均 (Life Sciences)0.8%アナリスト予想 (WAZ) (最長3年)0%注目すべき配当: WAZは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: WAZは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: WAZの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: WAZが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/17 01:12終値2026/08/17 00:00収益2026/07/04年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Waters Corporation 23 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。43 アナリスト機関Robert BambergerBairdCatherine Ramsey SchulteBairdCharles ButlerBarclays40 その他のアナリストを表示
お知らせ • Aug 06Waters Corporation Provides Earnings Guidance for the Third Quarter Ending October 3, 2026 and Full Fiscal Year Ending December 31, 2026Waters Corporation provided earnings guidance for the third quarter ending October 3, 2026 and Full Fiscal Year ending December 31, 2026. For the quarter, Total Company reported revenue for the third quarter of 2026 is expected to be in the range of $1.745 billion to $1.762 billion. For the Full-Year, total Company reported revenue for full-year 2026 is expected to be in the range of $6.415 billion to $6.476 billion.
Reported Earnings • Aug 04Second quarter 2026 earnings released: US$1.39 loss per share (vs US$2.47 profit in 2Q 2025)Second quarter 2026 results: US$1.39 loss per share (down from US$2.47 profit in 2Q 2025). Revenue: US$1.65b (up 113% from 2Q 2025). Net loss: US$136.0m (down 192% from profit in 2Q 2025). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Life Sciences industry in Europe.
お知らせ • Jul 28Waters Corporation Launches Xevo TQ Absolute XR IVD Mass SpectrometerWaters Corporation announced the launch of the Xevo TQ Absolute XR IVD Mass Spectrometer, expanding its MassTrak IVD System portfolio of LC-MS/MS Systems with a solution that combines class-leading sensitivity and enhanced robustness for clinical applications. The new system builds on the industry-renowned step-change performance of the Xevo TQ Absolute IVD Mass Spectrometer, which established the benchmark for sensitivity among IVD-compliant tandem quadrupole mass spectrometers. Developed for routine laboratory testing requiring IVD-compliant systems, the Xevo TQ Absolute XR IVD System delivers exceptional trace-level analytical performance in complex biological matrices. With up to five times greater sensitivity than other instruments in its class, the system enables lower limits of detection and reliable quantification of challenging analytes from smaller sample volumes. This enhanced sensitivity is critical for applications requiring accurate measurement at very low concentrations, such as low-level estradiol testing for women's health and hormone-related cancer assessment, and hair toxicology for detecting drugs of abuse and documenting long-term exposure. Featuring the new StepWave XR Ion Guide, the Xevo TQ Absolute XR IVD System delivers improved robustness, enabling ion ratio consistency for up to six times longer compared with the Xevo TQ Absolute IVD System. This advancement gives laboratories greater confidence in consistent performance when analyzing complex clinical samples containing phospholipids, salts, and other matrix components. This new MassTrak LC-MS/MS IVD System includes the ACQUITY UPLC I-Class PLUS System with the Xevo TQ Absolute XR IVD Mass Spectrometer. The ACQUITY UPLC I-Class PLUS System is designed to deliver fast, accurate sample analysis that enhances mass spectrometer performance and simplifies the characterization of complex samples. Together, the integrated system delivers industry-leading sensitivity, enhanced robustness for complex sample matrices, and a user-friendly design that helps maximize laboratory uptime.
お知らせ • Jul 02Waters Corporation to Report Q2, 2026 Results on Aug 04, 2026Waters Corporation announced that they will report Q2, 2026 results on Aug 04, 2026
お知らせ • Jun 29+ 6 more updatesWaters Corporation(NYSE:WAT) dropped from Russell 3000 Growth BenchmarkWaters Corporation(NYSE:WAT) dropped from Russell 3000 Growth Benchmark